Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 109

1.

Value of biomarkers in osteoarthritis: current status and perspectives.

Lotz M, Martel-Pelletier J, Christiansen C, Brandi ML, Bruyère O, Chapurlat R, Collette J, Cooper C, Giacovelli G, Kanis JA, Karsdal MA, Kraus V, Lems WF, Meulenbelt I, Pelletier JP, Raynauld JP, Reiter-Niesert S, Rizzoli R, Sandell LJ, Van Spil WE, Reginster JY.

Ann Rheum Dis. 2013 Nov;72(11):1756-63. doi: 10.1136/annrheumdis-2013-203726. Epub 2013 Jul 29. Review.

2.

Republished: Value of biomarkers in osteoarthritis: current status and perspectives.

Lotz M, Martel-Pelletier J, Christiansen C, Brandi ML, Bruyère O, Chapurlat R, Collette J, Cooper C, Giacovelli G, Kanis JA, Karsdal MA, Kraus V, Lems WF, Meulenbelt I, Pelletier JP, Raynauld JP, Reiter-Niesert S, Rizzoli R, Sandell LJ, Van Spil WE, Reginster JY.

Postgrad Med J. 2014 Mar;90(1061):171-8. doi: 10.1136/postgradmedj-2013-203726rep.

4.

Whole blood lead levels are associated with biomarkers of joint tissue metabolism in African American and white men and women: the Johnston County Osteoarthritis Project.

Nelson AE, Chaudhary S, Kraus VB, Fang F, Chen JC, Schwartz TA, Shi XA, Renner JB, Stabler TV, Helmick CG, Caldwell K, Poole AR, Jordan JM.

Environ Res. 2011 Nov;111(8):1208-14. doi: 10.1016/j.envres.2011.08.002. Epub 2011 Aug 12.

5.

Biomarkers in osteoarthritis.

Garnero P, Delmas PD.

Curr Opin Rheumatol. 2003 Sep;15(5):641-6. Review.

PMID:
12960494
6.

Cross-sectional association of 10 molecular markers of bone, cartilage, and synovium with disease activity and radiological joint damage in patients with hip osteoarthritis: the ECHODIAH cohort.

Garnero P, Mazières B, Guéguen A, Abbal M, Berdah L, Lequesne M, Nguyen M, Salles JP, Vignon E, Dougados M.

J Rheumatol. 2005 Apr;32(4):697-703.

PMID:
15801028
7.

Osteoarthritis year 2012 in review: biomarkers.

Mobasheri A.

Osteoarthritis Cartilage. 2012 Dec;20(12):1451-64. doi: 10.1016/j.joca.2012.07.009. Epub 2012 Jul 25. Review.

8.

Serum and urinary biochemical markers for knee and hip-osteoarthritis: a systematic review applying the consensus BIPED criteria.

van Spil WE, DeGroot J, Lems WF, Oostveen JC, Lafeber FP.

Osteoarthritis Cartilage. 2010 May;18(5):605-12. doi: 10.1016/j.joca.2010.01.012. Epub 2010 Feb 6. Review.

9.

Hyaluronan injection in murine osteoarthritis prevents TGFbeta 1-induced synovial neovascularization and fibrosis and maintains articular cartilage integrity by a CD44-dependent mechanism.

Li J, Gorski DJ, Anemaet W, Velasco J, Takeuchi J, Sandy JD, Plaas A.

Arthritis Res Ther. 2012 Jun 21;14(3):R151. doi: 10.1186/ar3887.

10.

Effect of advanced oxidation protein products on articular cartilage and synovium in a rabbit osteoarthritis model.

Yu H, Ye WB, Zhong ZM, Ding RT, Chen JT.

Orthop Surg. 2015 May;7(2):161-7. doi: 10.1111/os.12179.

PMID:
26033998
11.

The value of cartilage biomarkers in progressive knee osteoarthritis: cross-sectional and 6-year follow-up study in middle-aged subjects.

Kumm J, Tamm A, Lintrop M, Tamm A.

Rheumatol Int. 2013 Apr;33(4):903-11. doi: 10.1007/s00296-012-2463-8. Epub 2012 Jul 21.

PMID:
22821260
12.

Use of biochemical markers to study and follow patients with osteoarthritis.

Garnero P.

Curr Rheumatol Rep. 2006 Feb;8(1):37-44. Review.

PMID:
16515763
13.

Osteoarthritis, magnetic resonance imaging, and biochemical markers: a one year prospective study.

Bruyere O, Collette J, Kothari M, Zaim S, White D, Genant H, Peterfy C, Burlet N, Ethgen D, Montague T, Dabrowski C, Reginster JY.

Ann Rheum Dis. 2006 Aug;65(8):1050-4. Epub 2006 Jan 5.

14.

Osteoarthritis biomarkers derived from cartilage extracellular matrix: Current status and future perspectives.

Henrotin Y, Sanchez C, Bay-Jensen AC, Mobasheri A.

Ann Phys Rehabil Med. 2016 Jun;59(3):145-8. doi: 10.1016/j.rehab.2016.03.004. Epub 2016 Apr 28. Review.

15.

Identification of progressors in osteoarthritis by combining biochemical and MRI-based markers.

Dam EB, Loog M, Christiansen C, Byrjalsen I, Folkesson J, Nielsen M, Qazi AA, Pettersen PC, Garnero P, Karsdal MA.

Arthritis Res Ther. 2009;11(4):R115. doi: 10.1186/ar2774. Epub 2009 Jul 24.

16.

Applying Proteomics to Study Crosstalk at the Cartilage-Subchondral Bone Interface in Osteoarthritis: Current Status and Future Directions.

Fellows CR, Matta C, Mobasheri A.

EBioMedicine. 2016 Sep;11:2-4. doi: 10.1016/j.ebiom.2016.08.047. Epub 2016 Sep 3. No abstract available.

17.

Analysis of cartilage biomarkers in the early phases of canine experimental osteoarthritis.

Matyas JR, Atley L, Ionescu M, Eyre DR, Poole AR.

Arthritis Rheum. 2004 Feb;50(2):543-52.

18.

Biochemical markers of joint tissue turnover.

Bay-Jensen AC, Sondergaard BC, Christiansen C, Karsdal MA, Madsen SH, Qvist P.

Assay Drug Dev Technol. 2010 Feb;8(1):118-24. doi: 10.1089/adt.2009.0199. Review.

PMID:
19715454
19.

Biomarkers for osteoarthritis: Can they be used for risk assessment? A systematic review.

Hosnijeh FS, Runhaar J, van Meurs JB, Bierma-Zeinstra SM.

Maturitas. 2015 Sep;82(1):36-49. doi: 10.1016/j.maturitas.2015.04.004. Epub 2015 Apr 14. Review.

PMID:
25963100
20.

Recommendations for the use of new methods to assess the efficacy of disease-modifying drugs in the treatment of osteoarthritis.

Abadie E, Ethgen D, Avouac B, Bouvenot G, Branco J, Bruyere O, Calvo G, Devogelaer JP, Dreiser RL, Herrero-Beaumont G, Kahan A, Kreutz G, Laslop A, Lemmel EM, Nuki G, Van De Putte L, Vanhaelst L, Reginster JY; Group for the Respect of Excellence and Ethics in Science..

Osteoarthritis Cartilage. 2004 Apr;12(4):263-8. Review.

Supplemental Content

Support Center